Showing results (411-420 of 427) with videos related to

Sort By:
Pageof 43
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2022
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's diseaseXin Huang, Yihan Li, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay PlatformsJames D Doecke, Alan Rembach, Victor L Villemagne, et al.
Alzheimer'S Research & Therapy|November 20, 2015
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodologyAlan Rembach, Lisbeth A Evered, Qiao-Xin Li, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2025
Glucometabolic control and Anti-Transglutaminase Antibodies at Celiac Disease onset in Type 1 Diabetes youthFrancesca Di Candia, Francesco Maria Rosanio, Roberto Franceschi, et al.
Molecular Neurobiology|June 28, 2018
Chronic Metabolic Derangement-Induced Cognitive Deficits and Neurotoxicity Are Associated with REST InactivationAline Pertile Remor, Rodrigo Augusto da Silva, Filipe José de Matos, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Pageof 43